Ocular Surgery Archives

FDA Approves Bausch + Lomb’s Lotemax SM 0.38%

Approvals, FDA, FDA/Regulatory, Gels, Ocular Surgery, Ocular Tissues, Ophthalmics, Postoperative inflammation

The U.S. FDA approved Bausch + Lomb’s Lotemax SM (loteprednol etabonate ophthalmic gel) 0.38%, a new gel formulation for treating postoperative inflammation and pain following ocular surgery.

February 25, 2019/by PR Newswire

Bausch + Lomb Announces FDA Filing Acceptance

FDA/Regulatory, Ocular Surgery, Ophthalmics, PDUFA, Post-operative eye pain

Bausch + Lomb announced the U.S. FDA accepted the New Drug Application for the company’s sub-micron loteprednol etabonate ophthalmic gel 0.38% with a PDUFA date of Feb. 25, 2019.

July 9, 2018/by PR Newswire